Glox Therapeutics, a company developing precision antibiotic therapies based on naturally occurring bacteriocins, has been awarded a share of the £3 million Collaborative Discovery Programme (CDP) launched by the...

View the Online Magazine

Launches

Pioneer Group drives AI innovation in healthcare through industry and academic collaboration

Pioneer Group, the life science infrastructure and venture building specialist, has joined forces with Innovate UK, The Medical Research Council (MRC) and AstraZeneca, to...

New SWLP laboratory at Croydon Hospital transforms the diagnostic facility into one of the most advanced and innovative in the UK

South West London Pathology (SWLP) introduces cutting-edge technologies to its laboratories to create one of the most modern, innovative, and efficient clinical blood science...

Amazon Filters launches high-temp vent filter for pharma and biotech

A UK process filter manufacturer has launched an enhanced high-temperature-resistant membrane product aimed at vent applications across the global pharmaceutical and biotechnology markets. Amazon Filters’...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Er-Kim signs distribution agreement with the MEDICE Health Family for Vafseo in Central & Eastern Europe

Er-Kim, an international company specializing in the commercialization of novel therapies for pharmaceutical and biopharmaceutical companies, has signed a distribution agreement with the MEDICE...

Er-Kim extends exclusive distribution agreement with Ascendis to expand commercialization of endocrinology portfolio

Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, has extended its exclusive agreement with Danish biopharmaceutical company Ascendis Pharma to commercialize...

Camida wins Pharma Supplier of the Year!

The much-coveted title, Pharma Supplier of the Year, was bestowed upon Camida at the 2024 Pharma Industry Awards. (Wednesday, 30 October / Dublin, Ireland) Camida...

AscellaHealth acquires CHAPPER healthcare

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, has acquired CHAPPER healthcare, a global specialty pharmaceutical wholesaler, distributor and...

Approvals

Manufacturiung

Finance

Research & Development
Latest

Glox Therapeutics awarded share of £3m Collaborative Discovery Programme funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

Glox Therapeutics, a company developing precision antibiotic therapies based on naturally occurring bacteriocins, has been awarded a share of the £3 million Collaborative Discovery...

Lyndra forms strategic clinical research and commercial manufacturing services collaboration with Thermo Fisher for long-acting oral therapies

Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, has entered a strategic collaboration with Thermo Fisher Scientific, in which Thermo Fisher will...

AbbVie and Simcere Zaiming to develop novel trispecific antibody candidate in multiple myeloma

AbbVie and Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group, have announced an option to license agreement to develop SIM0500, an investigational new drug...

Gilead and LEO Pharma to accelerate development of oral STAT6 program with potential in inflammatory diseases

Gilead Sciences and LEO Pharma have announced a strategic partnership to accelerate the development and commercialization of LEO Pharma’s small molecule oral STAT6 (signal transducer...

Newron and Myung In Pharm announce license agreement for schizophrenia treatment in South Korea

Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for diseases of the central and peripheral nervous system, and Myung In...

Appointments